Find Ormetoprim manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 6981-18-6, Ormethoprim, Ormetorprim, 2,4-diamino-5-(6-methylveratryl)pyrimidine, Ro 5-9754, Component of rofenaid
Molecular Formula
C14H18N4O2
Molecular Weight
274.32  g/mol
InChI Key
KEEYRKYKLYARHO-UHFFFAOYSA-N
FDA UNII
M3EFS94984

Ormetoprim
1 2D Structure

Ormetoprim

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine
2.1.2 InChI
InChI=1S/C14H18N4O2/c1-8-4-11(19-2)12(20-3)6-9(8)5-10-7-17-14(16)18-13(10)15/h4,6-7H,5H2,1-3H3,(H4,15,16,17,18)
2.1.3 InChI Key
KEEYRKYKLYARHO-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC(=C(C=C1CC2=CN=C(N=C2N)N)OC)OC
2.2 Other Identifiers
2.2.1 UNII
M3EFS94984
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2,4-diamino-5-(6-methylveratryl)pyrimidine

2.3.2 Depositor-Supplied Synonyms

1. 6981-18-6

2. Ormethoprim

3. Ormetorprim

4. 2,4-diamino-5-(6-methylveratryl)pyrimidine

5. Ro 5-9754

6. Component Of Rofenaid

7. Ormetroprim

8. 5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine

9. 2,4-pyrimidinediamine, 5-[(4,5-dimethoxy-2-methylphenyl)methyl]-

10. 5-(4,5-dimethoxy-2-methylbenzyl)-2,4-diaminopyrimidine

11. 5-(4,5-dimethoxy-2-methylbenzyl)pyrimidine-2,4-diamine

12. Nsc-95072

13. M3efs94984

14. Nsc95072

15. Ro-59754

16. Ncgc00167523-01

17. Ormetoprim 100 Microg/ml In Acetonitrile

18. Ro-5-9754

19. 2,4-pyrimidinediamine, 5-((4,5-dimethoxy-2-methylphenyl)methyl)-

20. Dsstox_cid_26689

21. Dsstox_rid_81823

22. Dsstox_gsid_46689

23. Ormetoprima

24. Ormetoprime

25. Ormetoprimum

26. 5-[(4,5-dimethoxy-2-methyl-phenyl)methyl]pyrimidine-2,4-diamine

27. Smr000466374

28. Cas-6981-18-6

29. Ormetoprim [usan:inn]

30. Nsc 95072

31. Ormetoprime [inn-french]

32. Ormetoprimum [inn-latin]

33. Ormetoprima [inn-spanish]

34. Unii-m3efs94984

35. Einecs 230-246-6

36. Ormetoprim [inn]

37. Ormetoprim [jan]

38. Ormetoprim (usan/inn)

39. Ormetoprim [usan]

40. Ormetoprim [mart.]

41. Pyrimidine, 2,4-diamino-5-(6-methylveratryl)-

42. Nciopen2_006334

43. Schembl93810

44. Zinc562

45. Mls000759503

46. Mls001424067

47. Chembl494760

48. Ormetoprim [green Book]

49. 2,4-diamino-5-(4,5-dimethoxy-2-methylbenzyl)pyrimidin

50. Dtxsid1046689

51. Chebi:94553

52. Cv564

53. Hms2051k20

54. Hms3393k20

55. Bcp06018

56. Tox21_112520

57. Bdbm50413401

58. Mfcd00057747

59. S5290

60. Akos015917221

61. Tox21_112520_1

62. Ccg-100900

63. Nc00150

64. Sb60507

65. Ncgc00167523-02

66. Ncgc00167523-03

67. As-71719

68. Bo164180

69. Db-055351

70. Hy-121466

71. Sd-051044

72. Am20041036

73. Cs-0082144

74. Ft-0630358

75. O0424

76. Pyrimidine,4-diamino-5-(6-methylveratryl)-

77. D05273

78. T72844

79. 2, 5-[(4,5-dimethoxy-2-methylphenyl)methyl]-

80. Ab00639990-08

81. 981o186

82. A836658

83. W-104583

84. Q27166391

85. 2,4-diamino-5-(4,5-dimethoxy-2-methylbenzyl)pyrimidine

86. 5-(4,5-dimethoxy-2-methylbenzyl)-2,4-pyrimidinediamine

87. 2,4-diamino-5-(4,5-dimethoxy-2-methylbenzyl) Pyrimidine

88. 5-(4,5-dimethoxy-2-methyl-benzyl)-pyrimidine-2,4-diamine

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 274.32 g/mol
Molecular Formula C14H18N4O2
XLogP31.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass274.14297583 g/mol
Monoisotopic Mass274.14297583 g/mol
Topological Polar Surface Area96.3 Ų
Heavy Atom Count20
Formal Charge0
Complexity305
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty